Dr. Neil E. Faulkner
Claim this profileUniversity of Tennessee - Knoxville
Area of expertise
Lung Cancer
Neil E. Faulkner has run 5 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Neil E. Faulkner has run 4 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Tennessee - Knoxville
University Of Tennessee Medical Center
Clinical Trials Neil E. Faulkner is currently running
Fianlimab + Cemiplimab
for Non-Small Cell Lung Cancer
This trial is testing a new drug combination for patients with advanced lung cancer. It aims to see if using two drugs together is more effective than one alone. The study also looks at side effects, how the drugs are processed in the body, and their impact on quality of life.
Recruiting
0 awards
Phase 2 & 3
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
More about Neil E. Faulkner
Clinical Trial Related
2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Neil E. Faulkner has experience with
- Cemiplimab
- Fianlimab
- Paclitaxel
- Pemetrexed
- Carboplatin
- Pembrolizumab
Breakdown of trials Neil E. Faulkner has run
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Anaplastic Large Cell Lymphoma
ALK Gene Rearrangement
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Neil E. Faulkner specialize in?
Neil E. Faulkner focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Neil E. Faulkner currently recruiting for clinical trials?
Yes, Neil E. Faulkner is currently recruiting for 3 clinical trials in Knoxville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Neil E. Faulkner has studied deeply?
Yes, Neil E. Faulkner has studied treatments such as Cemiplimab, Fianlimab, Paclitaxel.
What is the best way to schedule an appointment with Neil E. Faulkner?
Apply for one of the trials that Neil E. Faulkner is conducting.
What is the office address of Neil E. Faulkner?
The office of Neil E. Faulkner is located at: University of Tennessee - Knoxville, Knoxville, Tennessee 37920 United States. This is the address for their practice at the University of Tennessee - Knoxville.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.